Active Awards Portfolio Dashboard

It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and clinical stage research. Check out our portfolio of active research awards in our interactive dashboard below. For a detailed list of CIRM-funded clinical trials, visit our Clinical Trials Dashboard.

Filter Awards

Disease Cell Type Therapeutic or Technology Institution Stage Project Objective Details
Leukemia, Acute Myeloid (AML) Cancer Stem Cell Antibody Immune-Onc Therapeutics
Clinical Trial, Phase 1 or Phase 1/2
Brain Cancer Adult Stem Cell Gene-modified, personalized cell therapy COH
Clinical Trial, Phase 1 or Phase 1/2
Brain Cancer Somatic Cell Gene-modified, personalized cell therapy UCSF
Pre-IND/IDE or Equivalent
Multiple Myeloma Adult Stem Cell Gene-modified, donor cell therapy UCLA
Pre-IND/IDE or Equivalent
Melanoma Adult Stem Cell Gene-modified, personalized cell therapy UCLA
Pre-IND/IDE or Equivalent
Amyotrophic Lateral Sclerosis Adult Stem Cell Gene-modified, donor cell therapy Cedars-Sinai
Clinical Trial, Phase 1 or Phase 1/2
Stroke Embryonic Stem Cell Donor cell therapy Stanford
Clinical Trial, Phase 1 or Phase 1/2
Brain Cancer Adult Stem Cell Gene-modified, personalized cell therapy Stanford
Clinical Trial, Phase 1 or Phase 1/2
Heart failure Embryonic Stem Cell Donor cell therapy Stanford
Clinical Trial, Phase 1 or Phase 1/2
Heart Disease iPS Cell Donor cell therapy UC Davis
Development Candidate, Proof of Concept
Pancreatic Cancer Cancer Stem Cell Small molecule therapy UCSD
Development Candidate, Proof of Concept
Liver Disease iPS Cell Diagnostic Test UCSF
Development Candidate, Proof of Concept
Brain Cancer,
Neurological Disorders
Embryonic Stem Cell Exosomes based therapy UC Irvine
Development Candidate, Proof of Concept
Anemia Adult Stem Cell,
iPS Cell
Small molecule therapy Stanford
Development Candidate, Proof of Concept
Heart failure iPS Cell Exosomes based therapy Stanford
Development Candidate, Proof of Concept
Angelman Syndrome,
Autism
iPS Cell Gene Therapy, cell free UC Davis
Development Candidate, Proof of Concept
Epidermolysis Bullosa iPS Cell Gene-modified, personalized cell therapy Stanford
Development Candidate, Proof of Concept
Ovarian Cancer iPS Cell Gene-modified, donor cell therapy UCSD
Development Candidate, Proof of Concept
Amyotrophic Lateral Sclerosis Adult Stem Cell Donor cell therapy UCSD
Development Candidate, Proof of Concept
Heart Disease iPS Cell Model system development Stanford
Development Candidate, Proof of Concept
Sickle Cell Disease Adult Stem Cell Gene-modified, personalized cell therapy UCSF
Clinical Trial, Phase 1 or Phase 1/2
Stanford

Pages

Icon for csv export